<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01631955</url>
  </required_header>
  <id_info>
    <org_study_id>KAUTII&amp;Schbc-UTI-QoL</org_study_id>
    <nct_id>NCT01631955</nct_id>
  </id_info>
  <brief_title>Assessment of UTI Symptoms and Quality of Life According to Antibiotics Treatment in Acute Uncomplicated Cystitis</brief_title>
  <official_title>A Study of Quality of Life and Changes to Symptom Relief for Acute Uncomplicated Cystitis Treated With Antibiotics (Ciprobay); Prospective, Open-label, Multicenter, Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Soonchunhyang University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Soonchunhyang University Hospital</source>
  <brief_summary>
    <textblock>
      Although Cystitis includes a clinical syndrome characterized by various combinations of
      dysuria (painful urination), frequency, urgency, gross haematuria, lower back and/or
      abdominal/suprapubic discomfort with pyuria and bacteriuria. An acute uncomplicated UTI
      (referred to as cystitis) has been focused microorganisms and drug-resistance. There has been
      little research on Clinical aspects on cystitis treatment such as bothersomeness, or the
      impact of symptoms on patients' quality of life (QoL). The investigators want to study for
      Assessment of UTI Symptoms and Quality of Life According to Antibiotics Treatment(Ciprobay)
      in Acute Uncomplicated Cystitis in Korean Women.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2009</start_date>
  <completion_date type="Actual">October 2011</completion_date>
  <primary_completion_date type="Actual">February 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Effect on patient satisfaction and quality of life.</measure>
    <time_frame>at day 5 relative to baseline</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in UTISA sub-category (dysuria, frequency, urgency, pain, hematuria)</measure>
    <time_frame>at day 10, 21 and 28 relative to baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in KHQ</measure>
    <time_frame>at day 10, 21 and 28 relative to baseline</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">386</enrollment>
  <condition>Acute Cystitis</condition>
  <arm_group>
    <arm_group_label>Cystitis</arm_group_label>
    <description>female with cystitis symptoms</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ciprobay</intervention_name>
    <description>Ciprobay (250mg, bid, oral)</description>
    <arm_group_label>Cystitis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Outpatient
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female outpatients (20-65 years old)

          -  Acute cystitis symptoms (subject-reported) for &lt; 1 week prior to Visit 1.

        Exclusion Criteria:

          -  Acute cystitis symptoms for ≥ 1 week prior to Visit 1.

          -  Diabetes mellitus

          -  Congenital urinary tract abnormality

          -  Female subjects who are pregnant, nursing, or with a positive urine pregnancy test or
             who are intending to become pregnant during the study or within 3 months after the
             completion of the study.

          -  Hypersensitivity to the active substance (Ciprobay).

          -  Subjects who have vaginal discharge

          -  Fever ( ≥ 37.5 ºC)

          -  Sexually transmitted diseases.

          -  Documented significant renal disease (sCr &gt; 1.5)

          -  Subjects who cannot consent to this study.

          -  Subjects who had received antimicrobial agents in the previous 4 weeks.

          -  Recurrent urinary tract infection defined as treatment for UTI &gt; 3 times in the last
             year.

          -  Use of an indwelling catheter or an intermittent self-catheterization program.

          -  Neurogenic bladder.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Min-Eui Kim, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Soonchunhyang University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Soonchunhyang University Bucheon Hospital</name>
      <address>
        <city>Bucheon</city>
        <state>Gyeonggi-do</state>
        <zip>420-767</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>June 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 27, 2012</study_first_submitted>
  <study_first_submitted_qc>June 28, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 29, 2012</study_first_posted>
  <last_update_submitted>June 28, 2012</last_update_submitted>
  <last_update_submitted_qc>June 28, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 29, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Soonchunhyang University Hospital</investigator_affiliation>
    <investigator_full_name>Kwang-Woo Lee, MD</investigator_full_name>
    <investigator_title>Department of urology</investigator_title>
  </responsible_party>
  <keyword>Acute cystitis</keyword>
  <keyword>Antibiotics</keyword>
  <keyword>Quality of life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cystitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

